Zoster immune globulin (ZIG) was found, in a double-blind study, to prevent varicella if a 2-ml dose was given to susceptible children within 72 hours of household exposure. Chicken pox developed in ...

Each of the 7 children received varicella zoster vaccination between 12 and 14 months of age. A case series published in the journal Pediatric Dermatology describes the occurrence of herpes zoster at ...

Symptomatic infection with the virus responsible for cold sores around the mouth–herpes simplex 1, or HSV-1 for short—may have a key role in the development of Alzheimer's disease, suggests a large US ...

At present, there is no effective prophylaxis against VZV reactivation, and HZ continues to be a significant cause of morbidity among HSCT patients. Continuous acyclovir prophylaxis post-HSCT may ...

Please provide your email address to receive an email when new articles are posted on . The live attenuated varicella-zoster vaccine is safe and provides “reasonable short-term” effectiveness in ...

The Centers for Disease Control and Prevention (CDC) has updated recommendations for the use of varicella-zoster immune globulin (VariZIG) to reduce the severity of infection by varicella-zoster virus ...

VARICELLA and herpes zoster are diseases with very different clinical manifestations and age distribution. However, the causative agents of the two syndromes have been shown to be indistinguishable ...

Background: Reactivation of herpes simplex virus type 1 is thought to be a major cause of adult idiopathic peripheral facial paralysis or Bell's palsy. However, few studies have examined the ...